Journal of Exotic Pet Medicine
Volume 17, Issue 1 , Pages 54-56 , January 2008

Amphotericin B

  • Megan Kirchgessner, DVM

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Megan S. Kirchgessner, DVM, New England Wildlife Center, South Weymouth, MA 02190 USA.

References 

  1. Ringden O, Meunier F, Tollemar J, et al. Efficacy of amphotericin B encapsulated in liposome (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother. 1991;28:73–82
  2. Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 1996;33:23–32
  3. Orosz SE, Frazier DL. Antifungal agents: a review of their pharmacology and therapeutic indications. J Avian Med Surg. 1995;9:8–18
  4. Petraitis V, Petraitiene R, Groll AH, et al. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrbo Agents Chemother. 2002;46:1857–1869
  5. Plumb D. Amphotericin B. In:  Plumb DC editors. Plumb’s Veterinary Drug Handbook. (ed 5). Ames, IA: Blackwell Publishing; 2005;p. 45–50
  6. Plotnick AN. Lipid-based formulations of amphotericin B. J Am Vet Med Assoc. 2000;216:838–841
  7. Wilson E, Tharson L, Speert DP. Enhancement of macrophage superoxide anion production by amphotericin B. Antimicrob Agents Chemother. 1991;35:796–800
  8. Flammer K. Antifungal therapy in avian medicine. Proc Annu West Vet Conf 1-4. 2003;
  9. Orosz SE. Antifungal drug therapy in avian species. Vet Clin North Am Exot Anim Pract. 2003;6:336–350
  10. Jukui H, Koike T, Saheki A, et al. Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS®). Int J Pharm. 2003;263:51–60
  11. Silvanose CD, Bailey TA, Di Somma A. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole. Vet Rec. 2006;159:282–284
  12. Redig PT, Duke GE. Comparative pharmacokinetics of antifungal drugs in domestic turkeys, red-tailed hawks, broad-winged hawks, and great-horned owls. Avian Dis. 1985;29:649–661
  13. Samour J. Pharmaceuticals commonly used in avian medicine. In:  Samour J editors. Avian Medicine. London: Mosby Publishing; 2000;p. 399
  14. Clubb SL. Birds. In:  Johnston DE editors. The Bristol Veterinary Handbook of Antimicrobial Therapy. (ed 2). Trenton, NJ: Veterinary Learning Systems; 1987;p. 188–199
  15. Murray MJ. Pneumonia and normal respiratory function. In:  Mader DM editors. Reptile Medicine and Surgery. Philadelphia: W.B. Saunders; 1996;p. 403
  16. Divers SJ. Empirical doses of antimicrobial drugs commonly used in reptiles. Exotic DVM. 1998;1:23
  17. Hernandez-Divers SJ. Pulmonary candidiasis caused by Candida albicans in a Greek tortoise (Testudo graeca) and treatment with intrapulmonary amphotericin B. J Zoo Wildl Med. 2001;32:352–359
  18. Wright K, Whitaker B. Pharmacotherapeutics. In:  Wright K,  Whitaker B editor. Amphibian Medicine and Surgery. Malabar, FL: Krieger Publishing Company; 2001;p. 314
  19. Besch-Williford CL. Biology and medicine of the ferret. Vet Clin North Am Small Anim Pract. 1987;17:1167–1168
  20. Sanati H, Ramos CF, Bayer AS, et al. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic mouse and infective endocarditis rabbit models. 1997;41:1345–1348
  21. Jukui H, Koike T, Saheki A, et al. A novel delivery system for amphotericin B with lipid nano-sphere (LNS®). Int J Pharm. 2003;265:37–45

PII: S1557-5063(07)00202-9

doi: 10.1053/j.jepm.2007.12.010

Journal of Exotic Pet Medicine
Volume 17, Issue 1 , Pages 54-56 , January 2008

Article Tools